LOPE vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

LOPE

45.7
AI Score
VS
UTI Wins

UTI

46.2
AI Score

Investment Advisor Scores

LOPE

46score
Recommendation
HOLD

UTI

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LOPE UTI Winner
Revenue 572.80M 661.15M UTI
Net Income 121.20M 15.54M LOPE
Net Margin 21.2% 2.4% LOPE
Operating Income 153.61M 19.27M LOPE
ROE 18.1% 4.5% LOPE
ROA 13.2% 1.7% LOPE
Total Assets 919.18M 897.86M LOPE
Cash 171.06M 130.06M LOPE
Current Ratio 2.82 1.30 LOPE

Relative Price Performance (Last 90 Days)

LOPE 1M: +8.3% · 3M: +16.5% UTI 1M: +3.9% · 3M: -43.9%

Current Technical Phase

LOPE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 66

RSI (14): 66.4 · Price: $163.09

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.5 · Price: $21.21

Fundamentals Snapshot

Metric LOPE UTI
Market Cap — —
Forward P/E 14.1 28.3
Trailing P/E 19.4 33.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.2% 0.0%
EPS 8.26 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.